ArrowArtboardCreated with Sketch.Title ChevronTitle ChevronIcon FacebookIcon LinkedinIcon Mail ContactPath LayerIcon MailPositive ArrowIcon PrintIcon Twitter

Otsuka, Daiichi Sankyo boost investment in cancer medication

Japanese drugmakers to enhance capacity, efficiency for growing field

A rendering of the production facility to be added to Taiho Pharmaceutical's Saitama plant.

TOKYO -- Japan's leading pharmaceutical companies are stepping up investment toward developing and producing cancer medication, preparing for the expected long-term growth in the field domestically and abroad.

In-house production

Sponsored Content

About Sponsored Content This content was commissioned by Nikkei's Global Business Bureau.

Discover the all new Nikkei Asia app

  • Take your reading anywhere with offline reading functions
  • Never miss a story with breaking news alerts
  • Customize your reading experience

Nikkei Asian Review, now known as Nikkei Asia, will be the voice of the Asian Century.

Celebrate our next chapter
Free access for everyone - Sep. 30

Find out more